Innovotech Inc  

(Public, CVE:IOT)   Watch this stock  
Find more results for IOT
0.0000 (0.00%)
Oct 1 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.01 - 0.06
Open     -
Vol / Avg. 500.00/6,760.00
Mkt cap 718,490.00
P/E     -
Div/yield     -
EPS 0.00
Shares 28.74M
Beta 0.01
Inst. own     -

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -50.59% -23.23%
Operating margin -38.80% -15.58%
EBITD margin - -10.06%
Return on average assets -107.63% -50.39%
Return on average equity - -
Employees 16 -
CDP Score - -


Suite 101, 2011-94 Street
+1-780-4480585 (Phone)
+1-780-4240941 (Fax)

Website links


Innovotech Inc. is a Canada-based company, which provides practical services and solutions for dealing with medical, agricultural and industrial problems caused by microbial biofilms. The Company is engaged in the sales of its products, conducting contract research for outside customers and research and development to identify products for future commercialization. The Company's products include human and veterinary biofilm susceptibility tests, a seed treatment designed to combat both bacterial and fungal diseases, and an assay used in growing microbial biofilms for research purposes. Its contract research specializes in solving biofilm issues and assembles data packages for regulatory applications required by the United States Food and Drug Administration (FDA) and other regulatory bodies for implant medical devices. Its lead product, InnovoSIL-1, has completed the proof-of-concept phase that demonstrated that InnovoSIL-1 eliminates microorganism.

Officers and directors

James Timourian Ph.D. Chairman of the Board, President, Chief Financial Officer
Bruce Darryl Hirsche Q.C. Corporate Secretary, Director
Age: 66
Bernard Grobbelaar Director
Robert B. Huizinga Director
Wolfgang H. Muhs Ph.D. Independent Director
Gerard Tertzakian Ph.D. Independent Director